Transcranial Magnetic Stimulation to Measure Cortical Excitability in Dravet Syndrome

UnknownOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Dravet Syndrome
Interventions
DEVICE

Transcranial Magnetic Stimulation (TMS)

Transcranial magnetic stimulation (TMS) is a method for noninvasive electrical cortical stimulation, where small intracranial currents are generated by a powerful, fluctuating, extracranial magnetic field. TMS is unique in its capacity for experimental, diagnostic, and therapeutic utility. Single pulse (spTMS) and paired-pulse TMS (ppTMS) have been used extensively to study, measure, and modulate cortical excitability and plasticity.

DEVICE

Electroencephalogram (EEG)

These will be an ambulatory EEG recordings that span 24 hours and done without sedation. Recordings will be performed using electrode locations specified by the international 10-20 system for standard clinical practice.

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Encoded Therapeutics

INDUSTRY

lead

Boston Children's Hospital

OTHER